Cellosaurus logo
expasy logo

Cellosaurus 201T (CVCL_X481)

[Text version]
Cell line name 201T
Accession CVCL_X481
Resource Identification Initiative To cite this cell line use: 201T (RRID:CVCL_X481)
Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
Part of: COSMIC cell lines project.
From: Siegfried J.M.; University of Pittsburgh; Pittsburgh; USA.
Population: African American.
Microsatellite instability: Instable (MSI-low) (Sanger).
Omics: Deep exome analysis.
Omics: Deep quantitative proteome analysis.
Omics: DNA methylation analysis.
Omics: SNP array analysis.
Omics: Transcriptome analysis by microarray.
Miscellaneous: Age of donor from personal communication of Siegfried J.M.
Derived from site: In situ; Lung; UBERON=UBERON_0002048.
Sequence variations
  • Mutation; HGNC; 11998; TP53; Simple; p.Ser241Ala (c.721T>G); ClinVar=VCV000376665; Zygosity=Homozygous (Cosmic-CLP; DepMap).
Genome ancestry Source: PubMed=30894373

Origin% genome
African88.81
Native American0
East Asian, North2.58
East Asian, South0
South Asian0
European, North3.06
European, South5.55
Disease Lung adenocarcinoma (NCIt: C3512)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 68Y
Category Cancer cell line
STR profile Source(s): Cosmic-CLP

Markers:
AmelogeninX,Y
CSF1PO7,13
D5S81812,13
D7S8209,10
D13S31711,13
D16S53911,12
TH017
TPOX6,8
vWA15

Run an STR similarity search on this cell line
Publications

PubMed=9816093
Kasprzyk P.G., Sullivan T.L., Hunt J.D., Gubish C.T., Scoppa C.A., Oelkuct M., Bird R.E., Fischer P.H., Siegfried J.M., King C.R.
Activity of anti-erbB-2 recombinant toxin OLX-209 on lung cancer cell lines in the absence of erbB-2 gene amplification.
Clin. Cancer Res. 2:75-80(1996)

PubMed=9816140
Skrepnik N., Araya J.C., Qian Z., Xu H.-B., Hamide J., Mera R., Hunt J.D.
Effects of anti-erbB-2 (HER-2/neu) recombinant oncotoxin AR209 on human non-small cell lung carcinoma grown orthotopically in athymic nude mice.
Clin. Cancer Res. 2:1851-1857(1996)

PubMed=10545285; DOI=10.1006/pupt.1999.0210
Siegfried J.M., Krishnamachary N., Gaither Davis A., Gubish C., Hunt J.D., Shriver S.P.
Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer.
Pulm. Pharmacol. Ther. 12:291-302(1999)

PubMed=15735034; DOI=10.1158/0008-5472.CAN-04-1872
Stabile L.P., Lyker J.S., Gubish C.T., Zhang W.-P., Grandis J.R., Siegfried J.M.
Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.
Cancer Res. 65:1459-1470(2005)

PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458
Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.
A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.
Cancer Res. 70:2158-2164(2010)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X.-M., Egan R.K., Liu Q.-S., Mironenko T., Mitropoulos X., Richardson L., Wang J.-H., Zhang T.-H., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747
Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Cancer Res. 79:1263-1273(2019)

PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010
Goncalves E., Poulos R.C., Cai Z.-X., Barthorpe S., Manda S.S., Lucas N., Beck A., Bucio-Noble D., Dausmann M., Hall C., Hecker M., Koh J., Lightfoot H., Mahboob S., Mali I., Morris J., Richardson L., Seneviratne A.J., Shepherd R., Sykes E., Thomas F., Valentini S., Williams S.G., Wu Y.-X., Xavier D., MacKenzie K.L., Hains P.G., Tully B., Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.
Pan-cancer proteomic map of 949 human cell lines.
Cancer Cell 40:835-849.e8(2022)

Cross-references
Cell line databases/resources cancercelllines; CVCL_X481
Cell_Model_Passport; SIDM00055
Cosmic-CLP; 1287381
DepMap; ACH-002089
Chemistry resources GDSC; 1287381
PharmacoDB; 201T_7_2019
Encyclopedic resources Wikidata; Q54583071
Gene expression databases ArrayExpress; E-MTAB-3610
GEO; GSM827492
GEO; GSM1669564
Polymorphism and mutation databases Cosmic; 910550
Progenetix; CVCL_X481
Proteomic databases PRIDE; PXD030304
Sequence databases EGA; EGAS00001000978
Entry history
Entry creation05-Sep-2014
Last entry update05-Oct-2023
Version number21